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Tetrahydrochromeno–quinoline derivatives are found to exhi-
bit a wide range of biological activities (Helmchen et al., 1986;
Yamanaka et al., 2000), including psychotropic, anti-allergic,
anti-inﬂammatory and estrogenic behavior (Munoz et al.,
1982; Yamada et al., 1992; Lee et al., 2004). Among them, Tet-
rahydrochromeno[4,3-b]quinolines are an important class of
1,4-dihydropyridines (DHPs) and NADH models (Fig. 1).
In the human body, 1,4-dihydropyridine compounds are
oxidized to pyridine derivatives by the action of cytochrome
P-450 in the liver (Guengerich et al., 1991). The oxidation of
1,4-DHPs to the corresponding pyridine derivatives constitutesthe principal metabolic route in biological systems as well as a
facile access to the corresponding pyridine derivatives (Stout
and Meyers, 1982), which show anti-hypoxic and anti-ischemic
activities from the easily available DHPs (Khadikar and
Borkat, 1998; Sabitha et al., 2003). Therefore, oxidative aroma-
tization of tetrahydrochromenoquinolines has attracted contin-
uing interests of organic and medicinal chemists and a plethora
of protocols has been developed.
Initially a series of novel tetrahydrochromeno[4,3-b]quino-
line derivatives(1a–n, Scheme 1) were prepared via the reaction
of 4-aminocoumarin with 2-benzylidene-cyclohexane-1,3-
dione derivatives in solvent free system at 200–210 C, accord-
ing to our recently reported work (Miri et al., 2011), and they
were used to investigate their conversion to the corresponding
pyridines.
Herein, we report a simple, efﬁcient and heterogeneous pro-
cedure for the aromatization of tetrahydrochromeno[4,3-
b]quinoline derivatives using SiO2–OSO3H/NaNO2/wet SiO2
at reﬂux in CHCl3.
Therefore, a variety of tetrahydrochromeno–quinoline
derivatives were subjected to aromatization via a combination
Table 1 Oxidative aromatization of novel tetrahydrochro-
meno[4,3-b]quinolines Using SSA/NaNO2.
GroupG Substrate Product MP(C) Yield (%)*
o-CH3 1a 2a 210–212 71
m-CH3 1b 2b 172–174 64
p-CH3 1c 2c 241–243 68
o-OCH3 1d 2d 180–182 71
m-OCH3 1e 2e 155–157 66
p-OCH3 1f 2f 185–187 75
o-Cl 1g 2g 253–255 66
m-Cl 1h 2h 188–190 68
p-Cl 1i 2i 281–283 70
m-NO2 1j 2j 161–163 70
p-NO2 1k 2k 265–267 67
m-Br 1l 2l 184–186 64
p-Br 1m 2m 279–281 65
H 1n 2n 121–123 74
* Isolated yield.
Figure 1 Structure of Hantzsch 1,4-DHPs I and chromeno[4,3-b]
quinolines II.
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high yields (Table 1).
Aromatization of tetrahydrochromeno[4,3-b]quinolines to
the corresponding pyridines was carried out under completely
heterogeneous conditions at reﬂuxing chloroform. The aroma-
tization procedure is very simple and the products are easily
isolated from the reaction media by simple ﬁltration and evap-
oration of chloroform.
In summary, in this paper we have introduced another abil-
ity of SiO2–OSO3H/NaNO2 as an efﬁcient oxidizing agent for
the oxidation of tetrahydrochromeno[4,3-b]quinolines under
heterogeneous conditions. Also the cheapness and availability
of the reagent, easy and clean work-up and high yields make
this method attractive for chemists.
2. Result and discussion
The prepared 7-aryl-9,10,11,12-tetrahydro-6H-chromeno[4,3-
b]quinoline-6,8-dione 1 were aromatized in the presence of sil-
ica sulfuric acid (Salehi et al., 2006), NaNO2 and wet SiO2 in
boiling chloroform (Miri et al., 2011). The presence of wet
SiO2 provides an effective heterogeneous surface area for the
in situ generation of nitrosonium ion (Scheme 2). This oxidiz-
ing reagent was used for converting thiols to their correspond-
ing thionitrils (Zolﬁgol, 2001). Application of the most
common oxidants for oxidation of dihydropyridines such as
CrO3 (Grinsteins et al., 1967), MnO2 (Vanden Eynde and
Mayence, 2003) ferric nitrate (Khadikar and Borkat, 1998;
Sadeghi et al., 2001) nicotinum dichromate (Sadeghi et al.,
2000) and Multi-wall Carbon Nanotubes modiﬁed with man-
ganese complex (MWNTs) was unsuccessful (Siswana et al.,
2008). The aromatization of DHPs afforded 7-Aryl-10,11-
dihydro-6H-chromeno[4,3-b]quinoline-6,8-dione 2 in 64–75%
yields (Table 1). The structure according to NMR (1H andO
Scheme 1 Oxidative aromatization of T13C, COSY, HMBC, HMQC) and EI-MS spectra was proved
to be aromatized 1,4-DHP cyclic with the formation of pyri-
dine cycle. The 1H NMR spectra showed the high deshielding
character of aliphatic protons from 1.8–2.9 in 1 to 2.18–3.41 in
2 which is attributed to the formation of pyridine. The protons
belonging to CH and NH in compounds 1 disappeared in com-
pounds 2. Mass spectrum and elemental analysis clearly sup-
port the proposed structure.3. Experimental
3.1. Materials and apparatus
Chemicals and all solvents used in this study were purchased
from Merck AG and Aldrich Chemical. Melting points were
determined on a Koﬂer hot stage apparatus and are uncor-
rected. The IR spectra were obtained on a Shimatdzu 470 spec-
trophotometer (potassium bromide disks). 1HNMR spectra
were measured using a Bruker FT-500 spectrometer, and
chemical shifts are expressed as d (ppm) with tetramethylsilane
as internal standard. The mass spectra were run on a Finnigan
TSQ-70 spectrometer at 70 eV. Merck silica gel 60 F254 plates
were used for analytical TLC; column chromatography was
performed on Merck silica gel (70–230 mesh). Yields are of
puriﬁed products and were not optimized.etrahydrochromeno[4,3-b]quinolines.
Scheme 2 The tentative mechanism for the oxidative aromatization of tetrahydrochromenoquinolines.
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9,10,11,12-tetrahydro-6H-chromeno[4,3-b]quinoline-6,8-dione
derivatives
Compounds 1a–n (5.4 mmol), sodium nitrite (l6 mmol, 1.1 g),
silica sulfuric acid (1.6 g) and silica gel (1.07 g) were reﬂuxed
in chloroform (100 ml) for 8 h. The mixture was cooled to
room temperature and ﬁltered. The ﬁltrate was evaporated
to dryness under reduced pressure, and the crude product
was puriﬁed by short column chromatography (20–80% ethyl
acetate/petroleum ether) to give 2a–n.
3.3. Spectral and physical data for selected compounds
3.3.1. 7-(2-Methylphenyl)-10,11-dihydro-6H-chromeno[4,3-
b]quinoline-6,8-dione (2a)
Yield = 71%, Mp = 210–212 C.
IR (KBr)m: 2922, 2848, 1754, 1691, 757 cm1.
1HNMR (CDCl3, 500 MHz), d (ppm): 2.02 (s, 3H, CH3),
2.24 (q, 2H, J= 6.6 Hz, H10), 2.66 (t, 2H, J= 6.6 Hz, H9),
3.38 (t, 2H, J= 6.6 Hz, H11), 6.81 (d, 1H, J= 7.0 Hz,
H15), 7.23 (t, 1H, J= 7.0 Hz H17), 7.28–7.35 (m, 3H, H16,
H18, H4), 7.40 (t, 1H, J= 8.0 Hz, H2), 7.61 (t, 1H,
J= 8.0 Hz, H3), 8.68 (d, 1H, J= 8.0 Hz, H1).
13C NMR(CDCl3-d), d: 20.01, 20.98, 34.61, 40.13, 115.13,
116.90, 118.83, 124.61, 124.89, 125.58, 126.09, 127.44, 127.69,
129.26, 133.33, 134.24, 137.84, 153.43, 154.13, 156.39, 157.92,
169.58, 196.14.MS: m/z (%), 355 (M+, 44), 340 (44), 327 (37), 299(100),
271(37), 151(50), 126 (50), 114 (63), 100(44), 87(25).
3.3.2. 7-(3-Cholorophenyl)-10,11-dihydro-6H-chromeno[4,3-
b]quinoline-6,8-dione (2h)
Yield = 68%, Mp = 188–190 C.
IR (KBr)m: 3018, 2853, 1744, 1691, 757 cm1.
1H NMR (CDCl3, 500 MHz), d (ppm): 2.23–2.28 (q, 2H,
J= 6.5 Hz, H10), 2.67–2.70 (t, 2H, J= 6.5 Hz, H9), 3.39–
3.40 (t, 2H, J= 6.5 Hz, H11), 7.02 (d, 1H, J= 7.0 Hz,
H16), 7.10 (s, 1H, H14), 7.30 (d, 1H, J= 8.0 Hz, H4), 7.37–
7.42 (m, 3H, H2, H17, H18), 7.62 (t, 1H, J= 8.0 Hz, H3),
8.68 (d, 1H, J= 8.0 Hz, H1).
13C NMR (CDCl3-d) d: 20.85, 34.57, 40.24, 114.86, 116.88,
118.64, 124.59, 124.72, 126.15, 126.27, 127.26, 127.62, 129.16,
133.49, 133.90, 139.79, 153.38, 154.04, 154.48, 158.07, 169.64,
196.08.
MS: m/z (%), 377 (M++2, 10), 375 (M+, 30), 340 (30),
319(27), 289(14), 227(44), 127 (44), 120 (100), 100(64),
87(32), 74(36).3.3.3. 7-(4-Bromophenyl)-10,11-dihydro-6H-chromeno[4,3-b]
quinoline-6,8-dione (2m)
Yield = 65%, Mp = 279–281 C.
IR (KBr)m: 3042, 2922, 1745, 1693, 771 cm1.
1H NMR (CDCl3, 500 MHz), d (ppm): 2.24 (q, 2H,
J= 6.5 Hz, H10), 2.67 (t, 2H, J= 6.5 Hz, H9), 3.38 (t, 2H,
J= 6.4 Hz, H11), 6.98 (d, 1H, J= 8.3 Hz, H14,H18), 7.32
S300 R. Motamedi et al.(d, 1H, J= 7.0 Hz, H4), 7.40(t, 1H, J= 7.0 Hz, H2), 7.58 (d,
1H, J= 8.3 Hz, H15, H17),7.62(t, 1H, J= 70 Hz, H3), 8.67
(d, 1H, J= 7.0 Hz, H1).
13C NMR (CDCl3-d), d: 20.87, 34.56, 40.28, 114.92,
116.91, 118.68, 124.71, 126.16, 126.26, 127.40, 127.91, 131.19,
133.48, 136.99, 153.39, 154.08, 155.10, 158.23, 169.57, 196.34.
MS: m/z (%), 421 (M++2, 11), 419 (M+, 11), 330(13),
289(100), 216(22), 149(20), 83(31), 57(76).References
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